HOLLY CHOLVIN: Open Payments
NPI 1619265006 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 7 payments from 5 companies in 2025. Trend: 2023 $56 · 2024 $81 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, REXULTI, COBENFY, Auvelity.
Industry payments across FL — which companies pay providers there.
